Maker Ajay V, Prabhakar Bellur, Pardiwala Krunal
Division of Surgical Oncology, Department of Surgery, University of Illinois at Chicago, Chicago Illinois, USA ; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago Illinois, USA.
Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago Illinois, USA.
J Clin Cell Immunol. 2015 Aug;6(4). doi: 10.4172/2155-9899.1000343. Epub 2015 Jul 22.
Rose Bengal (RB) is a red synthetic dye that was initially used in the garment industry and has been used safely for decades as a corneal stain by ophthalmologists. Antineoplastic properties of RB have also been observed, though the mechanism of action remained to be elucidated. Recently, interest in RB as a therapeutic cancer treatment has increased due to significant anti-tumor responses with direct tumor injection in human clinical trials for metastatic melanoma. In these patients, there has been the implication that RB may mount a T-cell mediated anti-tumor response and impart antigen-specific responses in distant bystander lesions. This article serves to evaluate the potential of intralesional rose bengal to stimulate T-cell mediated anti-tumor responses in in-vitro, pre-clinical, and clinical studies.
孟加拉玫瑰红(RB)是一种红色合成染料,最初用于服装行业,几十年来眼科医生一直将其作为角膜染色剂安全使用。人们也观察到了RB的抗肿瘤特性,但其作用机制仍有待阐明。最近,由于在转移性黑色素瘤的人体临床试验中直接向肿瘤内注射RB产生了显著的抗肿瘤反应,人们对RB作为一种癌症治疗方法的兴趣有所增加。在这些患者中,有迹象表明RB可能引发T细胞介导的抗肿瘤反应,并在远处的旁观者病变中产生抗原特异性反应。本文旨在评估瘤内注射孟加拉玫瑰红在体外、临床前和临床研究中刺激T细胞介导的抗肿瘤反应的潜力。